메뉴 건너뛰기




Volumn 38, Issue SUPPL. 1, 2005, Pages

Topic IV: Hormonal influence on treatment and the effect of treatments on contraceptive methods, continued - Data from the United States Food and Drug Administration

Author keywords

[No Author keywords available]

Indexed keywords

AMPRENAVIR; ANTIRETROVIRUS AGENT; CYTOCHROME P450 2B6; CYTOCHROME P450 3A4; EFAVIRENZ; ESTROGEN; ETHINYLESTRADIOL; FLUCONAZOLE; FOLLITROPIN; GESTAGEN; GESTODENE; GLUCURONOSYLTRANSFERASE; INDINAVIR; LEVONORGESTREL; LOPINAVIR PLUS RITONAVIR; LUTEINIZING HORMONE; NELFINAVIR; NEVIRAPINE; NORETHISTERONE; ORAL CONTRACEPTIVE AGENT; PROGESTERONE; PROTEINASE INHIBITOR; RIFABUTIN; RIFAMPICIN; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SEX HORMONE BINDING GLOBULIN;

EID: 18244373969     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper
Times cited : (1)

References (16)
  • 5
    • 0034872069 scopus 로고    scopus 로고
    • Contraceptive choices in HIV infected and HIV at-risk adolescent females
    • Belzer M, Rogers AS, Camarca M, et al., and the Adolescent Medicine HIV/AIDS Research Network. Contraceptive choices in HIV infected and HIV at-risk adolescent females. J Adolesc Health. 2001; 29 (3 Suppl.):93-100.
    • (2001) J Adolesc Health , vol.29 , Issue.3 SUPPL. , pp. 93-100
    • Belzer, M.1    Rogers, A.S.2    Camarca, M.3
  • 7
    • 84860935385 scopus 로고    scopus 로고
    • Ridgefield: Boehringer Ingelheim Pharmaceuticals, Inc
    • Viramune® prescription information. Ridgefield: Boehringer Ingelheim Pharmaceuticals, Inc; 2002.
    • (2002) Viramune® Prescription Information
  • 8
  • 9
  • 10
  • 13
    • 84860927359 scopus 로고    scopus 로고
    • New York: Bristol-Myers Squibb Company
    • Sustiva® prescription information. New York: Bristol-Myers Squibb Company; 2002.
    • (2002) Sustiva® Prescription Information
  • 14
    • 84860924255 scopus 로고    scopus 로고
    • Whitehouse Station: Merck and Co., Inc.
    • Crixivan® prescription information. Whitehouse Station: Merck and Co., Inc.; 2003.
    • (2003) Crixivan® Prescription Information
  • 16
    • 0025184340 scopus 로고
    • Mechanism-based inactivation of human liver microsomal cytochrome P-450 IIIA4 by gestodene
    • Guengerich FP. Mechanism-based inactivation of human liver microsomal cytochrome P-450 IIIA4 by gestodene. Chem Res Toxicol. 1990; 3:363-371.
    • (1990) Chem Res Toxicol , vol.3 , pp. 363-371
    • Guengerich, F.P.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.